Trial intelligence / Profile preview

Reno-protective effect of intraoperative dexmedetomidine infusion in cardiopulmonary bypass open heart surgery

TCTR20160601006Phase 4Not yet recruiting

Sponsor
Faculty of Medicine, Chulalongkorn University
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in chronic kidney disease (CKD), acute kidney failure (AKF), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Aug 2016; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

chronic kidney disease (CKD)acute kidney failure (AKF)

Beyond the preview

Go deeper on TCTR20160601006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160601006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call